Prestige Consumer Healthcare Inc. Investigation

Company: Prestige Consumer Healthcare Inc.

Ticker: (NYSE) PBH

See If You Qualify For Monetary Reward

Join the Prestige Consumer Healthcare Inc. Class Action Lawsuit

Investigation Details

During the Q3 FY 2026 earnings call, CEO Ron Lombardi stated that Prestige Consumer Healthcare anticipated a 57% adjusted gross margin in Q4. Management further projected projected free cash flow of $245 million or more for the full year alongside an adjusted EPS of $4.54. When Q4 results were reported, adjusted gross margin came in at approximately 55.4%, full-year free cash flow totaled $228 million, and adjusted diluted EPS was only 4.38; all three missed Prestige’s internal projections. Separately, Prestige Consumer Healthcare completed a $150 million acquisition of Australian skin-care firm LaCorium during the period. The acquisition was not discussed on the Q3 earnings call and was absent from the forward guidance framework presented to investors. PBH shares declined sharply following the Q4 disclosure.

Frequently Asked Questions

How do I join the lawsuit against Prestige Consumer Healthcare Inc. (NYSE: PBH)?

Investors who purchased shares of Prestige Consumer Healthcare Inc. (NYSE: PBH) during the class period (May 15, 2021 - May 15, 2026) can join by submitting their transaction details through this case page.

Ensure your purchase falls within the class period
Provide basic transaction and loss details
Submit your information before the deadline

The lead plaintiff deadline for this case is To be determined, so investors should act quickly to protect their rights.

Who is eligible for the Prestige Consumer Healthcare Inc. lawsuit?

Anyone who bought shares of Prestige Consumer Healthcare Inc. (NYSE: PBH) during May 15, 2021 - May 15, 2026 and suffered financial losses may qualify.

What is the lead plaintiff deadline to join the Prestige Consumer Healthcare Inc. case?

The lead plaintiff deadline for the Prestige Consumer Healthcare Inc. lawsuit is To be determined. Investors should act quickly to avoid missing this deadline.

What is the class period for Prestige Consumer Healthcare Inc.?

The class period for Prestige Consumer Healthcare Inc. (NYSE: PBH) is May 15, 2021 - May 15, 2026, during which investors may have been affected by alleged misconduct.

Can I still join the Prestige Consumer Healthcare Inc. lawsuit if I sold my shares?

Yes. Investors who purchased Prestige Consumer Healthcare Inc. shares during May 15, 2021 - May 15, 2026 may still qualify, even if they sold their shares later.

How much compensation can I receive from the Prestige Consumer Healthcare Inc. lawsuit?

Compensation depends on the total losses and the final settlement. Eligible investors in the Prestige Consumer Healthcare Inc. case may receive a portion of the recovery.

Do I need to pay to participate in the Prestige Consumer Healthcare Inc. case?

No, most securities fraud cases involving Prestige Consumer Healthcare Inc. operate on a contingency basis, meaning there are no upfront costs unless there is a recovery.

Will I need to appear in court for the Prestige Consumer Healthcare Inc. lawsuit?

In most cases, investors do not need to appear in court. The legal team manages the Prestige Consumer Healthcare Inc. case on behalf of participants.

What documents are required for the Prestige Consumer Healthcare Inc. lawsuit?

To participate in the Prestige Consumer Healthcare Inc. lawsuit, investors may need to provide transaction records, purchase dates, number of shares, and loss details.

What happens after I submit my trade information for Prestige Consumer Healthcare Inc.?

After submission, your details for the Prestige Consumer Healthcare Inc. case will be reviewed, and you may be contacted regarding eligibility or next steps.

Is this legal advice for the Prestige Consumer Healthcare Inc. lawsuit?

No, this page provides information about the Prestige Consumer Healthcare Inc. case and does not constitute legal advice or create an attorney-client relationship.

Why should I act quickly on the Prestige Consumer Healthcare Inc. case?

The lead plaintiff deadline for the Prestige Consumer Healthcare Inc. lawsuit is To be determined. If you are an investor, you may have the opportunity to seek appointment as lead plaintiff or remain an absent class member.